Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
Recruiting
N/A
Interventional Study
Crohn Disease
Recurrence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 16 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 236 (estimated)
- Sponsor
- Jinling Hospital, China · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with Crohn's disease needing bowel resection and anastomosis;
* ileocolic anastomosis；
* written consent acquired
Exclusion Criteria:
* patients underwent enterostomy;
* small bowel anastomosis;
* anticipating other trial.
Contacts